They reported that fibroblast-derived COL1A1 interacts with CD44 in malignant cells and that CXCL8-expressing CAFs and LAIR2 expression in Treg cells are associated with HNSCC progression8. The gene discussed is CXCL8; the disease is head and neck squamous cell carcinoma.